Form 4: Illumina's Chief Legal Officer, Scott M. Davies, Reports Acquisition of Restricted Stock Units and Performance Shares

Chief Legal Officer of Illumina, Scott M. Davies, reports the acquisition of restricted stock units and performance shares based on future performance metrics.

Summary

• On March 5, 2025, Scott M. Davies, Chief Legal Officer of Illumina, Inc., reported the acquisition of 7,002 shares of common stock and performance shares.
• These shares were acquired through restricted stock units and performance-based stock units.
• The restricted stock units vest in four equal installments on February 15 of 2026, 2027, 2028, and 2029.
• 8,169 performance shares are based on Illumina's three-year average operating margin for fiscal years 2025-2027, vesting on January 2, 2028.
• Another 8,169 performance shares are based on the company's relative total shareholder return for the fiscal year ending January 2, 2028, also vesting on January 2, 2028.
• The number of shares issued for both performance stock units will range from 0% to 250% of the specified amount, depending on performance against pre-defined objectives.

Sentiment

Score: 7

Explanation: The document itself is neutral, but the granting of performance-based compensation suggests confidence in the company's future performance, leading to a moderately positive sentiment.

Positives

• The acquisition of performance shares aligns the executive's interests with the company's long-term performance and shareholder value.
• The vesting schedule of the restricted stock units encourages continued service and commitment from the executive.

Risks

• The actual number of performance shares issued depends on the company's performance against pre-defined objectives, which introduces uncertainty.
• Failure to meet the performance objectives could result in fewer shares being issued.

Future Outlook

The number of performance shares ultimately vesting depends on Illumina's future financial performance, specifically its three-year average operating margin and relative total shareholder return.

Industry Context

This filing is a routine disclosure of executive compensation, common in publicly traded companies like Illumina. It reflects the company's strategy to incentivize executives through equity-based compensation tied to performance metrics.

Comparison to Industry Standards

• Equity-based compensation is a common practice among publicly traded companies, particularly in the technology and biotechnology sectors.
• Companies like Thermo Fisher Scientific and Danaher also utilize performance-based equity awards to align executive compensation with shareholder value creation.
• The specific metrics used, such as operating margin and total shareholder return, are typical indicators of company performance and are often used in executive compensation plans.

Stakeholder Impact

• Shareholders: The performance-based compensation aligns executive interests with shareholder value.
• Employees: The awards may motivate employees through the success of the company.

Key Dates